Page last updated: 2024-08-21

quinazolines and disulfiram

quinazolines has been researched along with disulfiram in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Evangelista, M; Merchant, M; Peng, J; Peterson, D; Raha, D; Settleman, J; Wilson, C; Wilson, TR; Yue, P	1
Cao, Q; Fu, SY; Li, Y; Wang, FY; Wang, LH; Wang, NN; Wang, YT; Wu, CF; Yang, JY	1

Other Studies

2 other study(ies) available for quinazolines and disulfiram

Article	Year
The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation. Cancer research, 2014, Jul-01, Volume: 74, Issue:13 Topics: Aldehyde Dehydrogenase; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Crizotinib; Disulfiram; DNA Damage; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; Oxidative Stress; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Quinazolines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Xenograft Model Antitumor Assays	2014
Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas. Cancer letters, 2015, Dec-01, Volume: 369, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Movement; Disulfiram; Drug Synergism; ErbB Receptors; Gefitinib; Glioma; Gluconates; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Quinazolines; Signal Transduction; src-Family Kinases; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2015

Article

Year

The cancer stem cell marker aldehyde dehydrogenase is required to maintain a drug-tolerant tumor cell subpopulation.

Cancer research, 2014, Jul-01, Volume: 74, Issue:13

Topics: Aldehyde Dehydrogenase; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Crizotinib; Disulfiram; DNA Damage; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Mice; Mice, Nude; Neoplastic Stem Cells; Oxidative Stress; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Quinazolines; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Xenograft Model Antitumor Assays

2014

Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas.

Cancer letters, 2015, Dec-01, Volume: 369, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Movement; Disulfiram; Drug Synergism; ErbB Receptors; Gefitinib; Glioma; Gluconates; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Quinazolines; Signal Transduction; src-Family Kinases; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2015